5 Facts you should know about

Cancer immunotherapy

Cancer immunotherapy exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them

Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill

Tumor immunotherapy includes Immune checkpoint inhibitors (ICIs), cellular immunotherapy, exosome immunotherapy, and other novel therapies

Compared with previous standards of care (including chemotherapy, radiotherapy, and surgery), cancer immunotherapy has brought significant improvements for patients in terms of survival and quality of life

Clinical success of cancer immunotherapy is highly variable between different forms of cancer

See our full disease profile

Rare Oncology News